<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Blood <z:chebi fb="19" ids="28790">serotonin</z:chebi> levels have been measured by spectrofluorometry in 145 patients with various manifestations of <z:hpo ids='HP_0011009'>acute</z:hpo> disorders of the cerebral circulation (ADCC): with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, cerebral hypertensive crises, transient impairments of the cerebral circulation, and with circulatory <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> (DE) in the presence of arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> combined with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In ADCC patients the blood <z:chebi fb="19" ids="28790">serotonin</z:chebi> has been measured 7 times, in DE ones 3 times </plain></SENT>
<SENT sid="2" pm="."><plain>This level has been found changed in the patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and with cerebral hypertensive crises for a long time after the cerebral circulation impairment </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="19" ids="28790">Serotonin</z:chebi> levels correlated with the condition severity and course in ADCC and DE </plain></SENT>
<SENT sid="4" pm="."><plain>The vestibulocerebellar syndrome in DE has been treated more effectively, particularly with trental </plain></SENT>
<SENT sid="5" pm="."><plain>The blood <z:chebi fb="19" ids="28790">serotonin</z:chebi> level may be regarded as a prognostic criterion of the disease outcome and of the treatment efficacy </plain></SENT>
</text></document>